3-4 June 2019 NanoMed final symposium, Eindhoven

June 3-4, 2019 the final NanoMed symposium will be held in Eindhoven, The Netherlands. There is a public part (registration mandatory) on the afternoon of June 4th. Watch this space for further updates.

3-5 December 2018: SFNano (French Society for Nanomedicine meeting)

Since 2014, the French Society for Nanomedicine (SFNano) has organized three national meetings in Nancy, Paris and Bordeaux, as well as a summer school on Nucleic Acid Delivery in 2017 and the European Nanomedicine Meeting (ENM15) in Grenoble in 2015. This year SFNano will be held in Montpellier, France, from December 3rd to 5th.

This is a great opportunity to gather and share your ideas and perspectives in the field of Nanomedicine. Scientific sessions will allow to be up-to date in the field of characterization, cancer, immunology, imaging and topical delivery, thanks to the excellent speakers on the roster, namely Ernst Wagner, Vasilis Ntziachristos, Jean-Christophe Leroux, Pascal DumyBéhazine Combadière, Karine Breckpot, Igor Clarot, Janos Szebeni, Pablo Taboada, Rabah Boukherroub and Jean-Marie Devoisselle. Do not miss the Biotech corner to discover the local biotech companies and the Young SFNano session with 3 minute-presentations from PhDs and post-docs. Communicate more deeply on the subjects during the poster sessions and in the convivial atmosphere of the Gala dinner.

Registration and abstract submission are now opened: http://www.sfnano.fr/montpellier/

The tentative program is available on the website.

Please note the submission deadline of September 30th!

SF Nano 2018

Promo flyer SF Nano 2018 (click for large version)

19-20 November 2018: Next NanoMed meeting at Synthon and ChemConnection

The next NanoMed meeting will be held at partner Synthon and beneficiary ChemConnection in November. During this meeting there will be training sessions and lectures which we, with the help of our company partners, will focus on business development, the formation and management of a start-up company, intellectual property aspects, licensing, regulatory aspects, et cetera.